U.S. flag

An official website of the United States government

NM_000102.4(CYP17A1):c.1039C>T (p.Arg347Cys) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 25, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003555893.2

Allele description [Variation Report for NM_000102.4(CYP17A1):c.1039C>T (p.Arg347Cys)]

NM_000102.4(CYP17A1):c.1039C>T (p.Arg347Cys)

Gene:
CYP17A1:cytochrome P450 family 17 subfamily A member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q24.32
Genomic location:
Preferred name:
NM_000102.4(CYP17A1):c.1039C>T (p.Arg347Cys)
HGVS:
  • NC_000010.11:g.102832611G>A
  • NG_007955.1:g.9923C>T
  • NM_000102.4:c.1039C>TMANE SELECT
  • NP_000093.1:p.Arg347Cys
  • NC_000010.10:g.104592368G>A
  • NM_000102.3:c.1039C>T
  • P05093:p.Arg347Cys
Protein change:
R347C; ARG347CYS
Links:
UniProtKB: P05093#VAR_022752; OMIM: 609300.0021; dbSNP: rs104894149
NCBI 1000 Genomes Browser:
rs104894149
Molecular consequence:
  • NM_000102.4:c.1039C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004295706Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 25, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The genetic and functional basis of isolated 17,20-lyase deficiency.

Geller DH, Auchus RJ, Mendonça BB, Miller WL.

Nat Genet. 1997 Oct;17(2):201-5.

PubMed [citation]
PMID:
9326943

Control of androgen biosynthesis in the human through the interaction of Arg347 and Arg358 of CYP17 with cytochrome b5.

Lee-Robichaud P, Akhtar ME, Akhtar M.

Biochem J. 1998 Jun 1;332 ( Pt 2):293-6.

PubMed [citation]
PMID:
9601054
PMCID:
PMC1219480
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004295706.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 347 of the CYP17A1 protein (p.Arg347Cys). This variant is present in population databases (rs104894149, gnomAD 0.004%). This missense change has been observed in individual(s) with isolated 17,20-lyase deficiency (PMID: 12466376). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1794). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYP17A1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CYP17A1 function (PMID: 12466376). This variant disrupts the p.Arg347 amino acid residue in CYP17A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9326943, 9601054, 12466376, 27426448). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024